https://biovacsafe.eu/2016/05/29/activities-of-biovacsafe-partners/2020-09-23T09:31:50+01:00https://biovacsafe.eu/2016/06/29/new-publications-acknowledging-biovacsafe/2020-09-23T09:31:27+01:00https://biovacsafe.eu/2012/06/18/immunoarray-com/2020-09-23T09:30:51+01:00https://biovacsafe.eu/2012/06/18/gothenburg/2020-09-23T09:30:24+01:00https://biovacsafe.eu/2012/06/18/lancement-de-biovacsafe-mieux-comprendre-les-mecanismes-immunitaires-impliques-dans-la-vaccination/2020-08-03T08:00:04+01:00https://biovacsafe.eu/2012/06/12/surrey-researchers-accelerate-procedures-to-test-and-monitor-vaccine-safety/2020-08-03T08:01:04+01:00https://biovacsafe.eu/2012/06/12/nieuw-consortium-rond-veiligheid-van-vaccins/2020-08-03T08:02:07+01:00https://biovacsafe.eu/2012/06/08/surrey-researchers-accelerate-procedures-to-test-and-monitor-vaccine-safety-2/2020-08-03T08:02:53+01:00https://biovacsafe.eu/2012/06/08/imi-215m-euros-to-tackle-major-research-challenges/2020-08-03T08:03:36+01:00https://biovacsafe.eu/2012/06/07/scienza-in-rete/2020-08-03T08:04:54+01:00https://biovacsafe.eu/2012/06/07/e-partito-il-progetto-biovacsafe-biomarkers-for-enhanced-vaccine-safety-universita-di-siena-e-novartis-vaccines-and-diagnostics-protagonisti-insieme-ad-altri-17-partner-europei/2020-08-03T08:05:44+01:00https://biovacsafe.eu/2012/06/26/per-la-sicurezza-ce-biovac/2020-08-03T08:06:51+01:00https://biovacsafe.eu/2012/06/18/e-partito-il-progetto-biovacsafe-universita-di-siena-e-novartis-vaccines-and-diagnostics-protagonisti/2020-08-03T08:07:38+01:00https://biovacsafe.eu/2012/06/18/sanita-per-il-progetto-biovacsafe-302-milioni-di-euro-di-investimenti/2020-08-03T08:08:22+01:00https://biovacsafe.eu/2012/06/18/ricerca-intesa-universita-siena-novartis/2020-08-03T08:09:02+01:00https://biovacsafe.eu/2012/06/18/universita-novartis-e-17-altri-partner-nel-progetto-biovacsafe/2020-08-03T08:09:36+01:00https://biovacsafe.eu/2012/06/19/parte-progetto-vaccini-sicuri-da-302mln/2020-08-03T08:10:17+01:00https://biovacsafe.eu/2012/06/19/parte-progetto-vaccini-sicuri-da-302mln-2/2020-08-03T08:10:58+01:00https://biovacsafe.eu/2012/06/19/salute-al-via-progetto-vaccini-sicuri-investimenti-per-30-2-mln/2020-08-03T08:11:31+01:00https://biovacsafe.eu/2016/09/19/tgf-s-in-immunity-inflammation-and-cancer-a3/2020-08-03T08:19:59+01:00https://biovacsafe.eu/2016/09/19/keystone-symposia-new-developments-in-our-basic-understanding-of-tuberculosis/2020-08-03T08:20:51+01:00https://biovacsafe.eu/2016/09/19/global-summit-on-immunology/2020-08-03T08:21:20+01:00https://biovacsafe.eu/2016/09/19/keystone-symposia-viral-immunity-mechanisms-and-consequences/2020-08-03T08:21:46+01:00https://biovacsafe.eu/2016/09/19/12th-annual-biomarkers-congress/2020-08-03T08:22:13+01:00https://biovacsafe.eu/2016/09/19/11th-world-immune-regulation-meeting/2020-08-03T08:22:41+01:00https://biovacsafe.eu/2016/09/30/biomarker-summit/2020-08-03T08:23:19+01:00https://biovacsafe.eu/2016/09/30/ici-2017-19th-international-conference-on-immunology/2020-08-03T08:23:52+01:00https://biovacsafe.eu/2016/09/19/more-events/2020-08-03T08:24:44+01:00https://biovacsafe.eu/2018/04/23/early-career-research-prize-in-vaccinology-rd-2018/2020-09-23T09:28:39+01:00https://biovacsafe.eu/2017/04/23/5th-biovacsafe-annual-meeting/2020-09-23T09:29:39+01:00